HKPD Stock Summary and Trading Ideas (Cellyan Biotechnology Co. - Class A | NASDAQ:HKPD)

Cellyan Biotechnology Co Ltd is an integrated pharmaceutical cross-border e-commerce supply chain service provider with a professional team and related pharmaceutical storage facilities in Hong Kong. It operates through two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, referred to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, referred to as the Procurement and Distribution division. Its main business provides one-stop services for merchants engaged in cross-border pharmaceutical e-commerce, including OTC wholesale, import and export, warehousing, packaging, customs clearance and delivery to final destinations, forming a closed loop of pharmaceutical cross-border e-commerce supply chain.

Cellyan Biotechnology Co. - Class A trades on the NASDAQ stock market under the symbol HKPD.

As of September 15, 2026, HKPD stock price declined to $0.11 with 1,481,436 million shares trading.

HKPD has a beta of 1.57, meaning it tends to be more sensitive to market movements. HKPD has a correlation of 0.02 to the broad based SPY ETF.

HKPD has a market cap of $5.59 million. This is considered a Sub-Micro Cap stock.

HKPD has underperformed the market in the last year with a price return of -91.6% while the SPY ETF gained +16.4%. HKPD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -72.7% and -66.0%, respectively, while the SPY returned +2.4% and -1.3%, respectively.

HKPD support price is $.11 and resistance is $.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HKPD shares will trade within this expected range on the day.